Skinceuticals Silymarin Cf Acne Treatment Antioxidant

Description

The drug is identified by the SPL code 34089-3. The effective time of the insert is recorded as 20240624. Additionally, the insert contains multimedia elements, including an image categorized as "image/jpeg," with a reference value of "SKCSilymarin4mlBottle.jpg."

Uses and Indications

This drug is indicated for the treatment of acne. It is effective in reducing the number and severity of acne blemishes, thereby facilitating the healing of the skin.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The affected area should be covered with a thin layer of the product one to three times daily, depending on the patient's needs and the physician's recommendations.

It is advisable to initiate treatment with one application per day to minimize the risk of excessive drying of the skin. Based on the patient's response, the frequency of application may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once daily or every other day to alleviate these symptoms.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. This product is intended solely for topical application and should not be ingested. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Healthcare professionals are advised to monitor patients for signs of skin irritation and dryness, particularly in cases where this product is used concurrently with other topical acne medications. The likelihood of experiencing skin irritation increases when multiple topical agents are applied simultaneously. Should any irritation occur, it is recommended that the use of this product be discontinued, and the patient should consult their healthcare provider. Only one topical acne medication should be utilized at a time to minimize the risk of adverse effects.

Side Effects

Patients should be advised that the product is for external use only. This warning is critical to ensure safe and appropriate use of the product, as improper application may lead to adverse effects. No specific adverse reactions have been reported in clinical trials or postmarketing experiences beyond this warning. It is essential for patients to adhere strictly to the recommended usage guidelines to minimize any potential risks associated with misuse.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical acne medications and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Skinceuticals Silymarin Cf Acne Treatment Antioxidant (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely to ensure the medication is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased to two or three times daily as needed or as directed by a healthcare professional.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is currently no information available regarding the use of SKINCEUTICALS SILYMARIN CF ACNE TREATMENT ANTIOXIDANT (salicylic acid solution) during pregnancy. This includes any safety concerns, dosage modifications, or special precautions that may be necessary for pregnant patients. Given the lack of data, healthcare professionals should exercise caution when considering the use of this product in pregnant patients and weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be advised to discuss their pregnancy status and any concerns with their healthcare provider before using this product.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any considerations related to lactation. Healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants have not been established.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert text. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist may also be beneficial in guiding the management of the overdose.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the potential risks associated with accidental ingestion.

Additionally, healthcare providers should inform patients about the likelihood of skin irritation and dryness when using this medication concurrently with other topical acne treatments. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation. This guidance is essential for ensuring the safe and effective use of the medication.

Storage and Handling

The product is supplied in a configuration that ensures optimal preservation of its integrity. It is essential to store the product in a cool, dark place to maintain its efficacy. Additionally, it must be kept away from flames and heat sources to prevent degradation or potential hazards. Proper handling and storage conditions are crucial for ensuring the safety and effectiveness of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Skinceuticals Silymarin Cf Acne Treatment Antioxidant, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)